Association between higher plasma lutein, zeaxanthin, and vitamin C concentrations and longer telomere length: Results of the Austrian Stroke Prevention Study

Journal of the American Geriatrics Society

Volumn 62, Issue 2, 2014, Pages 222-229

  Sen, Abhijit ^a   Marsche, Gunther ^a   Freudenberger, Paul ^a   Schallert, Michael ^a   Toeglhofer, Anna M ^a   Nagl, Christoph ^a   Schmidt, Reinhold ^a   Launer, Lenore J ^b   Schmidt, Helena ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

aging; antioxidants; lutein zeaxanthin; oxidative stress; telomere length; vitamin C

Indexed keywords

AGING; ANTIOXIDANTS; LUTEIN ZEAXANTHIN; OXIDATIVE STRESS; TELOMERE LENGTH; VITAMIN C;

AGED; AGED, 80 AND OVER; AGING; ANTIOXIDANTS; ASCORBIC ACID; AUSTRIA; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROSS-SECTIONAL STUDIES; DNA; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LEUKOCYTES; LUTEIN; MALE; MIDDLE AGED; OXIDATIVE STRESS; REAL-TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; SPECTROPHOTOMETRY; STROKE; TELOMERE HOMEOSTASIS; XANTHOPHYLLS;

EID: 84894092673     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/jgs.12644     Document Type: Article

References (51)

1. Blackburn EH,. Telomeres and telomerase: Their mechanisms of action and the effects of altering their functions. FEBS Lett 2005; 579: 859-862.
2. Aviv A,. Telomeres and human aging: Facts and fibs. Sci Aging Knowledge Environ 2004; 51: 43.
3. Frenck RW, Blackburn EH, Shannon KM,. The rate of telomere sequence loss in human leukocytes varies with age. Proc Natl Acad Sci USA 1998; 95: 5607-5610.
4. Fitzpatrick AL, Kronmal RA, Gardner JP, et al. Leukocyte telomere length and cardiovascular disease in the Cardiovascular Health Study. Am J Epidemiol 2007; 165: 14-21.
5. O'Donnell CJ, Demissie S, Kimura M, et al. Leukocyte telomere length and carotid artery intimal medial thickness: The Framingham Heart Study. Arterioscler Thromb Vasc Biol 2008; 28: 1165-1171.
6. Salpea KD, Talmud PJ, Cooper JA, et al. Association of telomere length with type 2 diabetes, oxidative stress and UCP2 gene variation. Atherosclerosis 2010; 209: 42-50.
7. Demissie S, Levy D, Benjamin EJ, et al. Insulin resistance, oxidative stress, hypertension, and leukocyte telomere length in men from the Framingham Heart Study. Aging Cell 2006; 5: 325-330.
8. Vasan RS, Demissie S, Kimura M, et al. Association of leukocyte telomere length with circulating biomarkers of the renin-angiotensin-aldosterone system: The Framingham Heart Study. Circulation 2008; 117: 1138-1144.
9. Jang JS, Choi YY, Lee WK, et al. Telomere length and the risk of lung cancer. Cancer Sci 2008; 99: 1385-1389.
10. Cawthon RM, Smith KR, O'Brien E, et al. Association between telomere length in blood and mortality in people aged 60 years or older. Lancet 2003; 361: 393-395.
11. Njajou OT, Cawthon RM, Damcott CM, et al. Telomere length is paternally inherited and is associated with parental lifespan. Proc Natl Acad Sci USA 2007; 104: 12135-12139.
12. Valdes AM, Andrew T, Gardner JP, et al. Obesity, cigarette smoking, and telomere length in women. Lancet 2005; 366: 662-664.
13. Robertson T, Batty GD, Der G, et al. Is socioeconomic status associated with biological aging as measured by telomere length? Epidemiol Rev 2013; 35: 98-111.
14. Cassidy A, De Vivo I, Liu Y, et al. Associations between diet, lifestyle factors, and telomere length in women. Am J Clin Nutr 2010; 91: 1273-1280.
15. Epel ES, Blackburn EH, Lin J, et al. Accelerated telomere shortening in response to life stress. Proc Natl Acad Sci USA 2004; 101: 17312-17315.
16. von Zglinicki T,. Oxidative stress shortens telomeres. Trends Biochem Sci 2002; 27: 339-344.
17. Jeyapalan JC, Ferreira M, Sedivy JM, et al. Accumulation of senescent cells in mitotic tissue of aging primates. Mech Ageing Dev 2007; 128: 36-44.
18. Farzaneh-Far R, Lin J, Epel ES, et al. Association of marine omega-3 fatty acid levels with telomeric aging in patients with coronary heart disease. JAMA 2010; 303: 250-257.
19. Chen L, Stacewicz-Sapuntzakis M, Duncan C, et al. Oxidative DNA damage in prostate cancer patients consuming tomato sauce-based entrees as a whole-food intervention. Natl Cancer Inst 2001; 93: 1872-1879.
20. Xu Q, Parks CG, DeRoo LA, et al. Multivitamin use and telomere length in women. Am J Clin Nutr 2009; 89: 1857-1863.
21. Witko-Sarsat V, Friedlander M, Capeillère-Blandin C, et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 1996; 49: 1304-1313.
22. Schmidt R, Fazekas F, Kapeller P, et al. MRI white matter hyperintensities: Three-year follow-up of the Austrian Stroke Prevention Study. Neurology 1999; 53: 132-139.
23. Cawthon RM,. Telomere measurement by quantitative PCR. Nucleic Acids Res 2002; 30: e47.
24. Cawthon RM,. Telomere length measurement by a novel monochrome multiplex quantitative PCR method. Nucleic Acids Res 2009; 37: e21.
25. Schmidt R, Hayn M, Fazekas F, et al. Magnetic resonance imaging white matter hyperintensities in clinically normal elderly individuals: Correlations with plasma concentrations of naturally occurring antioxidants. Stroke 1996; 27: 2043-2047.
26. World Health Organization. World Health Statistics Annual: The WHO MONICA Project. Geneva, Switzerland: World Health Organization, 1989.
27. Marsche G, Frank S, Hrzenjak A, et al. Plasma-advanced oxidation protein products are potent high-density lipoprotein receptor antagonists in vivo. Circ Res 2009; 104: 750-757.
28. Preacher KJ, Hayes AF,. Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behav Res Methods 2008; 40: 879-891.
29. Sen A, Gider P, Cavalieri M, et al. Association of cardiorespiratory fitness and morphological brain changes in the elderly: Results of the Austrian Stroke Prevention Study. Neurodegener Dis 2012; 10: 135-137.
30. Mares-Perlman JA, Millen AE, Ficek TL, et al. The body of evidence to support a protective role for lutein and zeaxanthin in delaying chronic disease. Overview. J Nutr 2002; 132: 518S-524S.
31. Myint PK, Luben RN, Welch AA, et al. Plasma vitamin C concentrations predict risk of incident stroke over 10 y in 20649 participants of the European Prospective Investigation into Cancer Norfolk prospective population study. Am J Clin Nutr 2008; 87: 64-69.
32. Steffen LM, Jacobs DR Jr, Stevens J, et al. Associations of whole-grain, refined-grain, and fruit and vegetable consumption with risks of all-cause mortality and incident coronary artery disease and ischemic stroke: The Atherosclerosis Risk in Communities (ARIC) Study. Am J Clin Nutr 2003; 78: 383-390.
33. Padayatty SJ, Katz A, Wang Y, et al. Vitamin C as an antioxidant: Evaluation of its role in disease prevention. J Am Coll Nutr 2003; 22: 18-35.
34. Surtees PG, Wainwright NW, Pooley KA, et al. Educational attainment and mean leukocyte telomere length in women in the European Prospective Investigation into Cancer (EPIC)-Norfolk population study. Brain Behav Immun 2012; 26: 414-418.
35. Richards JB, Valdes AM, Gardner JP, et al. Higher serum vitamin D concentrations are associated with longer leukocyte telomere length in women. Am J Clin Nutr 2007; 86: 1420-1425.
36. Santocono ZM, Berrettini M, Fedeli D, et al. Lutein, zeaxanthin and astaxanthin protect against DNA damage in SK-N-SH human neuroblastoma cells induced by reactive nitrogen species. J Photochem Photobiol B Biol 2007; 88: 1-10.
37. Azqueta A, Collins AR,. Carotenoids and DNA damage. Mutat Res 2012; 733: 4-13.
38. Cooke MS, Evans MD, Podmore ID, et al. Novel repair action of vitamin C upon in vivo oxidative DNA damage. FEBS Lett 1998; 439: 363-367.
39. Furumoto K, Inoue E, Nagao N, et al. Age-dependent telomere shortening is slowed down by enrichment of intracellular vitamin C via suppression of oxidative stress. Life Sci 1998; 63: 935-948.
40. Kim HW, Chew BP, Wong TS, et al. Modulation of humoral and cell mediated immune responses by dietary lutein in cats. Vet Immunol Immunopathol 2000; 73: 331-341.
41. Härtel C, Puzik A, Göpel W, et al. Immunomodulatory effect of vitamin C on intracytoplasmic cytokine production in neonatal cord blood cells. Neonatology 2007; 91: 54-60.
42. Dwyer JH, Paul-Labrador MJ, Fan J, et al. Progression of carotid intima-media thickness and plasma antioxidants: The Los Angeles Atherosclerosis Study. Arterioscler Thromb Vasc Biol 2004; 24: 313-319.
43. Wannamethee SG, Lowe GD, Rumley A, et al. Associations of vitamin C status, fruit and vegetable intakes, and markers of inflammation and hemostasis. Am J Clin Nutr 2006; 83: 567-574.
44. Sumantran VN, Zhang R, Lee DS, et al. Differential regulation of apoptosis in normal versus transformed mammary epithelium by lutein and retinoic acid. Cancer Epidemiol Biomarkers Prev 2000; 9: 257-263.
45. Perez-Cruz I, Carcamo JM, Golde DW,. Vitamin C inhibits FAS-induced apoptosis in monocytes and U937 cells. Blood 2003; 102: 336-343.
46. Panush RS, Delafuente JC, Katz P, et al. Modulation of certain immunologic responses by vitamin C. III. Potentiation of in vitro and in vivo lymphocyte responses. Int J Vitam Nutr Res Suppl 1982; 23: 35-47.
47. Heller R, Unbehaun A, Schellenberg B, et al. L-ascorbic acid potentiates endothelial nitric oxide synthesis via a chemical stabilization of tetrahydrobiopterin. J Biol Chem 2001; 276: 40-47.
48. Ignarro LJ, Cirino G, Casini A, et al. Nitric oxide as a signaling molecule in the vascular system: An overview. J Cardiovasc Pharmacol 1999; 34: 879-886.
49. Grasselli A, Nanni S, Colussi C, et al. Estrogen receptor-alpha and endothelial nitric oxide synthase nuclear complex regulates transcription of human telomerase. Circ Res 2008; 103: 34-42.
50. Vasa M, Breitschopf K, Zeiher AM, et al. Nitric oxide activates telomerase and delays endothelial cell senescence. Circ Res 2000; 87: 540-542.
51. Vioque J, Weinbrenner T, Asensio L, et al. Plasma concentrations of carotenoids and vitamin C are better correlated with dietary intake in normal weight than overweight and obese elderly subjects. Br J Nutr 2007; 97: 977-986.